Literature DB >> 18343788

Clinical role of p16INK4a expression in liquid-based cervical cytology: correlation with HPV testing and histologic diagnosis.

Maria Benevolo1, Amina Vocaturo, Marcella Mottolese, Luciano Mariani, Giuseppe Vocaturo, Ferdinando Marandino, Isabella Sperduti, Francesca Rollo, Barbara Antoniani, Raffaele Perrone Donnorso.   

Abstract

p16INK4a is overexpressed in high-risk human papillomavirus (HR-HPV)-infected preneoplastic and neoplastic lesions of the uterine cervix. Our aim was to verify whether p16 is a diagnostic marker also in cervical liquid-based cytology. We performed p16 immunocytochemical analysis and the Hybrid Capture 2 (HC2) test (Digene, Gaithersburg, MD) for HR-HPV infection in 471 ThinPrep-processed (Cytyc, Boxborough, MA) cervicovaginal samples and correlated the results with histologic findings. A total of 32.3% of the specimens showed p16 immunoreactivity, whereas the HC2 test was positive in 41.2% of the cases (65.2% concordance rate). Correlating the cytologic, p16, and HPV results with histologic findings revealed HC2 as the most sensitive test for a diagnosis of cervical intraepithelial neoplasia 2 or worse, whereas cytologic examination was the most specific. The positive predictive value was significantly higher for cytologic examination than for p16 and HR-HPV testing. These data suggest that p16 evaluation in ThinPrep samples does not have better clinical effectiveness for identifying high-grade lesions than conventional morphologic examination and HPV testing.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18343788     DOI: 10.1309/BEPQXTCQD61RGFMJ

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

Review 1.  p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis.

Authors:  Jolien Roelens; Miriam Reuschenbach; Magnus von Knebel Doeberitz; Nicolas Wentzensen; Christine Bergeron; Marc Arbyn
Journal:  Cancer Cytopathol       Date:  2012-06-14       Impact factor: 5.284

2.  Comparison of conventional and liquid-based cytology, and human papillomavirus testing using SurePath preparation in Japan.

Authors:  Hideki Taoka; Yasuhiro Yamamoto; Nobuyuki Sakurai; Mami Fukuda; Yasuyuki Asakawa; Akiko Kurasaki; Toshiaki Oharaseki; Kaneyuki Kubushiro
Journal:  Hum Cell       Date:  2010-11-17       Impact factor: 4.174

3.  Combined detection of p16(INK4a) and IMP3 increase the concordance rate between cervical cytologic and histologic diagnosis.

Authors:  Qingzhu Wei; Bo Fu; Jianghuan Liu; Jiabao Xu; Tong Zhao
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15

Review 4.  Cervical cancer screening in developing countries at a crossroad: Emerging technologies and policy choices.

Authors:  Rosa Catarino; Patrick Petignat; Gabriel Dongui; Pierre Vassilakos
Journal:  World J Clin Oncol       Date:  2015-12-10

5.  Comparative accuracy of anal and cervical cytology in screening for moderate to severe dysplasia by magnification guided punch biopsy: a meta-analysis.

Authors:  Wm Christopher Mathews; Wollelaw Agmas; Edward Cachay
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

Review 6.  Relative accuracy of cervical and anal cytology for detection of high grade lesions by colposcope guided biopsy: a cut-point meta-analytic comparison.

Authors:  Edward R Cachay; Wollelaw Agmas; William C Mathews
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

7.  Multicentre Evaluation of Hepika Test Clinical Accuracy in Diagnosing HPV-Induced Cancer and Precancerous Lesions of the Uterine Cervix.

Authors:  Daniela Gustinucci; Lucia Ciccocioppo; Luigi Coppola; Giovanni Negri; Gianfranco Zannoni; Basilio Passamonti; Elena Cesarini; Ciro Ianzano; Tiziana Andreano; Anjuta Pireddu; Paolo Giorgi-Rossi
Journal:  Diagnostics (Basel)       Date:  2021-03-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.